HIV Diagnostics Market Share, Size, Trends and Forecasts to 2022

  • Published on
    27-Jul-2016

  • View
    214

  • Download
    2

DESCRIPTION

Global HIV Diagnostics Market is expected to reach USD 4.48 billion by 2022, growing at an estimated CAGR of 9.5% from 2015 to 2022, according to a new study by Grand View Research, Inc. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource limited settings

Transcript

  • Hexa Reports Market Research Reports and Insightful Company Profiles

    Global HIV Diagnostics Market Share, Size, Trends and Growth, By Product Analysis, Application and Segment Forecasts To 2022

    Global HIV Diagnostics Market is expected to reach USD 4.48 billion by 2022, growing at an

    estimated CAGR of 9.5% from 2015 to 2022, according to a new study by Grand View

    Research, Inc. Key factors accounting for the growth of this market include the growing need in

    for the development of more sensitive HIV diagnostic point of care tests which can be easily

    implemented at the location of patient care in resource limited settings. Technological

    development of tests which is expected to introduce a number of novel rapid, point-of-care tests

    throughout the forecast period is a primary factor expected to fuel the growth of the HIV

    diagnostics market. Furthermore, government programs and campaigns initiated against HIV,

    global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in

    the Middle Eastern and Eastern regions of the market are some key factors expected to serve as

    lucrative future growth opportunities.

    Browse Detail Report With TOC @ http://www.hexareports.com/report/global-hiv-diagnostics-market-analysis-by-product/details

    Further key findings from the study suggest:

    Antibody HIV diagnostic tests accounted for the largest share of the market in 2014. This large

    share can be accounted for by the high market usage and penetration rates of these tests which

    include, ELISA, home access dried blood spot, western blot testing IFA and RIPA. These tests

  • Hexa Reports Market Research Reports and Insightful Company Profiles

    are highly sensitive and accurate and thus are most commonly used for screening and

    confirmation of HIV-1 & HIV-2.

    Viral Load testing and CD4 testing also accounted for a considerable share of the market in

    2014. There is a prevalent in the market for the development of these tests which will make them

    more sensitive, rapid in nature and portable to the point of care to enhance their market usability

    and accessibility in resource limited HIV affected regions.

    It is expected that during the forecast period a number of novel point of care HIV diagnostic

    products will be commercialized which are currently under clinical development and in product

    pipelines of key market players. This increase in the range of products s expected to fuel the

    growth of this market over the forecast period.

    North America was observed to account for the largest share of the market in 2014, which can be

    attributed to the presence of a strong healthcare R&D scenario in which the presence of

    government funding and ongoing corporate efforts to enhance product portfolio are anticipated to

    accelerate the timelines for new product development. Furthermore, the presence of favorable

    reimbursements policies for HIV and other infectious diseases is also a factor accounting for this

    regions large share.

    Asia Pacific is expected to grow at a relatively faster rate over the forecast period owing to, the

    presence of high levels of unmet market demand for HIV screening and testing. Moreover,

    collaborations among market participants from the western regions is another significant

    expected to boost the growth of Asia Pacific HIV diagnostics market during the forecast period.

    Key players of the market include Janssen Diagnostics, Daktari Diagnostics, Cepheid, Hologic

    and Chembio Diagnostic Systmes Inc.

    Request A Sample copy of This Report @ http://www.hexareports.com/sample/98139 Table of Contents

    HIV Diagnostics Product Outlook (Revenue, USD Million, 2012 2022)

    Antibody Tests

    HIV-1 Screening Tests

    ELISA/EIA

    Home Access Dried Blood Spot

    Rapid Tests (Dot plot, Agglutination Tests)

  • Hexa Reports Market Research Reports and Insightful Company Profiles

    HIV-1 Antibody Confirmatory Tests

    Western Blot Test

    ndirect Immunofluorescent Antibody Assay (IFA)

    Line Immunoassay

    RadioImmunoPrecipitation Assay (RIPA)

    HIV-2 & Group O Diagnostic Tests

    Blood Antibody Tests

    Dried Blood Spot (DBS) Test

    Others and (Oral, Urine)

    Viral Identification Assays

    P24 Antigen Test

    Qualitative PCR Tests

    Viral Culture

    CD4 Testing

    Viral Load Testing

    Early Infant Diagnostics

    HIV Diagnostics Regional Outlook (Revenue, USD Million, 2012 2022)

    North America

    U.S.

    U.S. HIV Diagnostics Market, by Product

    Canada

    Canada HIV Diagnostics Market, by Product

    Europe

    Germany

    Germany HIV Diagnostics Market, by Product

    UK

    UK HIV Diagnostics Market, by Product

    Asia Pacific

    Japan

    Japan HIV Diagnostics Market, by Product

    China

    China HIV Diagnostics Market, by Product

    Latin America

    Brazil

    Brazil HIV Diagnostics Market, by Product

    MEA

  • Hexa Reports Market Research Reports and Insightful Company Profiles

    South Africa

    South Africa HIV Diagnostics Market, by Product Browse Full Report @ http://www.hexareports.com/report/global-hiv-diagnostics-market-analysis-by-product/details About Us:

    Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in

Recommended

View more >